{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:29:22Z","timestamp":1778833762665,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T00:00:00Z","timestamp":1478649600000},"content-version":"am","delay-in-days":405,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP38614"],"award-info":[{"award-number":["OPP38614"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1033104"],"award-info":[{"award-number":["OPP1033104"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AI060354"],"award-info":[{"award-number":["AI060354"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["OD011103"],"award-info":[{"award-number":["OD011103"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AI067854"],"award-info":[{"award-number":["AI067854"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AI100645"],"award-info":[{"award-number":["AI100645"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AI057157"],"award-info":[{"award-number":["AI057157"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AI058607"],"award-info":[{"award-number":["AI058607"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation Graduate Research Fellowship","doi-asserted-by":"publisher","award":["2011083676"],"award-info":[{"award-number":["2011083676"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["HHSN266200400091C"],"award-info":[{"award-number":["HHSN266200400091C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.vaccine.2015.07.010","type":"journal-article","created":{"date-parts":[[2015,7,18]],"date-time":"2015-07-18T01:08:56Z","timestamp":1437181736000},"page":"5715-5722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Rhesus immune responses to SIV Gag expressed by recombinant BCG vectors are independent from pre-existing mycobacterial immunity"],"prefix":"10.1016","volume":"33","author":[{"given":"Birgit","family":"Korioth-Schmitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey C.","family":"Perley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaimie D.","family":"Sixsmith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva M.","family":"Click","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunhee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman L.","family":"Letvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Frothingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.07.010_bib0200","series-title":"Global tuberculosis report 2013","first-page":"306","author":"World Health Organization","year":"2013"},{"issue":"RR-4","key":"10.1016\/j.vaccine.2015.07.010_bib0205","first-page":"1","article-title":"The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices","volume":"45","author":"Centers for Disease Control","year":"1996","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0210","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0215","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.vaccine.2004.08.039","article-title":"Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines","volume":"23","author":"Dennehy","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0220","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/351456a0","article-title":"New use of BCG for recombinant vaccines","volume":"351","author":"Stover","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0225","first-page":"159","article-title":"Development of BCG as a live recombinant vector system: potential use as an HIV vaccine","volume":"2","author":"Fuerst","year":"1991","journal-title":"Biotechnol Ther"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0230","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1128\/CVI.00184-12","article-title":"A recombinant attenuated Mycobacterium tuberculosis vaccine strain is safe in immunosuppressed simian immunodeficiency virus-infected infant macaques","volume":"19","author":"Jensen","year":"2012","journal-title":"Clin Vaccine Immunol: CVI"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0235","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.trivac.2013.09.005","article-title":"A neonatal oral-SIV prime\/intramuscular MVA-SIV boost combination vaccine induces both SIV and -specific immune responses in infant macaques","volume":"2","author":"Jensen","year":"2013","journal-title":"Trials Vaccinol"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0240","doi-asserted-by":"crossref","first-page":"e42559","DOI":"10.1371\/journal.pone.0042559","article-title":"Pre-clinical development of BCG.HIVA(CAT), an antibiotic-free selection strain, for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG","volume":"7","author":"Saubi","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0245","doi-asserted-by":"crossref","first-page":"e20067","DOI":"10.1371\/journal.pone.0020067","article-title":"Dual neonate vaccine platform against HIV-1 and M. tuberculosis","volume":"6","author":"Hopkins","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0250","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.1128\/JVI.00726-10","article-title":"Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques","volume":"84","author":"Rosario","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0255","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1128\/CVI.00324-14","article-title":"Recombinant Mycobacterium bovis bacillus Calmette\u2013Guerin vectors prime for strong cellular responses to simian immunodeficiency virus gag in rhesus macaques","volume":"21","author":"Sixsmith","year":"2014","journal-title":"Clin Vaccine Immunol: CVI"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0260","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1128\/CVI.00195-06","article-title":"Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatis","volume":"13","author":"Yu","year":"2006","journal-title":"Clin Vaccine Immunol: CVI"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0265","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1128\/JVI.02544-08","article-title":"Recombinant Mycobacterium bovis BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional simian immunodeficiency virus-specific T-cell responses","volume":"83","author":"Cayabyab","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0270","doi-asserted-by":"crossref","first-page":"e98938","DOI":"10.1371\/journal.pone.0098938","article-title":"The human antibody response to the surface of Mycobacterium tuberculosis","volume":"9","author":"Perley","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0275","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1189\/jlb.0606407","article-title":"Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination","volume":"80","author":"Flaherty","year":"2006","journal-title":"J Leukocyte Biol"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0280","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/IAI.70.2.672-678.2002","article-title":"Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis","volume":"70","author":"Brandt","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0285","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.4049\/jimmunol.172.10.6290","article-title":"Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity","volume":"172","author":"Barouch","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0290","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.coi.2011.03.006","article-title":"Viral vectors as vaccine platforms: deployment in sight","volume":"23","author":"Rollier","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0295","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1089\/hum.2008.033","article-title":"Impact of preexisting vector immunity on the efficacy of adeno-associated virus-based HIV-1 Gag vaccines","volume":"19","author":"Lin","year":"2008","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0300","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-4419-1132-2_14","article-title":"Innovative approaches to develop prophylactic and therapeutic vaccines against HIV\/AIDS","volume":"655","author":"Cafaro","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0305","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fimmu.2014.00028","article-title":"Pre-clinical assessment of immune responses to adeno-associated virus (AAV) vectors","volume":"5","author":"Basner-Tschakarjan","year":"2014","journal-title":"Frontiers Immunol"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0310","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.4049\/jimmunol.1000751","article-title":"Preexisting vaccinia virus immunity decreases SIV-specific cellular immunity but does not diminish humoral immunity and efficacy of a DNA\/MVA vaccine","volume":"185","author":"Kannanganat","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0315","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.micinf.2007.07.010","article-title":"Pre-existing anti-Salmonella vector immunity prevents the development of protective antigen-specific CD8 T-cell frequencies against murine listeriosis","volume":"9","author":"Sevil Domenech","year":"2007","journal-title":"Microbes Infect\/Inst Pasteur"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0320","series-title":"Guide for the care and use of laboratory animals","author":"National Research Council","year":"2011"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0325","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1084\/jem.187.9.1373","article-title":"Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex","volume":"187","author":"Kuroda","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0330","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0335","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1016\/j.vaccine.2011.05.023","article-title":"Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial","volume":"29","author":"Barreto","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0340","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1128\/IAI.73.4.2190-2196.2005","article-title":"Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens","volume":"73","author":"Demangel","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0345","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-3083.1997.d01-99.x","article-title":"Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-Group","volume":"46","author":"Lozes","year":"1997","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0350","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(02)08353-8","article-title":"BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies","volume":"359","author":"Black","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0355","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.tpb.2009.01.006","article-title":"Mycobacterial ecology as a modulator of tuberculosis vaccine success","volume":"75","author":"Mantilla-Beniers","year":"2009","journal-title":"Theor Popul Biol"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0360","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nm.1991","article-title":"Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans","volume":"15","author":"O\u2019Brien","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0365","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrmicro1211","article-title":"The success and failure of BCG\u2014implications for a novel tuberculosis vaccine","volume":"3","author":"Andersen","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0370","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1099\/jmm.0.070425-0","article-title":"Vaccine against tuberculosis: a view","volume":"63","author":"Parkash","year":"2014","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0375","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.1016\/j.vaccine.2007.10.025","article-title":"The effect of tuberculin skin test and BCG vaccination on the expansion of PPD-specific IFN-gamma producing cells ex vivo","volume":"25","author":"Ota","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0380","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept step study: a case-cohort analysis","volume":"372","author":"McElrath","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0385","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1128\/IAI.01274-08","article-title":"Impact of preexisting vector-specific immunity on vaccine potency: characterization of listeria monocytogenes-specific humoral and cellular immunity in humans and modeling studies using recombinant vaccines in mice","volume":"77","author":"Leong","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.07.010_bib0390","doi-asserted-by":"crossref","first-page":"591348","DOI":"10.1155\/2010\/591348","article-title":"Development of Th1 imprints to rBCG expressing a foreign protein: implications for vaccination against HIV-1 and diverse influenza strains","volume":"2010","author":"Power","year":"2010","journal-title":"J Biomed Biotechnol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15009445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15009445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:22:12Z","timestamp":1759400532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15009445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":39,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0264410X15009445"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rhesus immune responses to SIV Gag expressed by recombinant BCG vectors are independent from pre-existing mycobacterial immunity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}